Oregon’s Health Authority announced that it would end a round of rulemaking without adopting proposed increases to psilocybin license fees. In its September 22 statement, the agency cited comments from licensees, advisory groups and the public. The decision concerned the fee proposal. The agency also said it planned to revisit other program rules separately. Readers comparing an older proposal with their obligations can use the dated statement to understand which changes the agency declined to adopt.